
|Articles|January 30, 2006
FDA panel wants to ban certain OTC asthma inhalers
Advertisement
An FDA advisory panel has voted 11-7 to recommend that the FDA ban certain nonprescription inhalers because they contain propellants that harm the ozone layer. Among the products that would be affected by a ban is Wyeth Consumer Healthcare's Primatene Mist.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D
3
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
4
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
5







































